Raju Subramanian
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 15
- Nephrology top 5%
- Parathyroid Disorders and Treatments 7
- Spectroscopy top 5%
- Virology top 10%
- HIV Research and Treatment 6
-
- PI3K/AKT/mTOR signaling in cancer 7
- Metabolomics and Mass Spectrometry Studies 5
-
- Drug Transport and Resistance Mechanisms 7
-
- Pharmacological Effects and Toxicity Studies 7
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Thomayant PrueksaritanontXiaochun ZhuYue QiuJiunn H. LinShuguang MaK.V. BhagwatYuping ChenCuyue Tang
- Cited by
- PharmacologyNephrologySpectroscopy
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Raju Subramanian
74 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 370
- Nephrology 127
- Spectroscopy 237
- Computational Theory and Mathematics 180
- Virology 51
Countries citing papers authored by Raju Subramanian
This map shows the geographic impact of Raju Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raju Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raju Subramanian more than expected).
Fields of papers citing papers by Raju Subramanian
This network shows the impact of papers produced by Raju Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raju Subramanian. The network helps show where Raju Subramanian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raju Subramanian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 5 | |
| 10 | 2019 | 22 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 21 | |
| 13 | 2014 | 6 | |
| 14 | 2010 | 9 | |
| 15 | 2008 | 7 | |
| 16 | 2007 | 41 | |
| 17 | 2006 | 126 | |
| 18 | 2002 | 10 | |
| 19 | 2002 | 276 | |
| 20 | 1998 | 51 |
About Raju Subramanian
Raju Subramanian is a scholar working on Nuclear Energy and Engineering, Pharmacology and Virology, having authored 75 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Parathyroid Disorders and Treatments (7 papers), HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Pharmacology (370 citations), Nephrology (127 citations) and Spectroscopy (237 citations). Raju Subramanian has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Thomayant Prueksaritanont, Xiaochun Zhu, Yue Qiu, Jiunn H. Lin, Shuguang Ma, K.V. Bhagwat, Yuping Chen, Cuyue Tang, Bennett Ma and Xiaojun Fang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.